HST
39
-5
CI
49
3
XYL
60
-2
CSX
39
-4
CINF
58
4
FLS
75
8
APA
30
5
DLTR
44
-7
GWW
51
-2
TSN
38
-2
BMY
35
2
L
63
3
QRVO
34
-4
ALL
50
2
CFG
56
4
EOG
49
4
CAT
69
3
FMC
31
-3
MCK
73
2
KSS
47
-4
HST
39
-5
CI
49
3
XYL
60
-2
CSX
39
-4
CINF
58
4
FLS
75
8
APA
30
5
DLTR
44
-7
GWW
51
-2
TSN
38
-2
BMY
35
2
L
63
3
QRVO
34
-4
ALL
50
2
CFG
56
4
EOG
49
4
CAT
69
3
FMC
31
-3
MCK
73
2
KSS
47
-4
Financhill
Back

Chemomab Therapeutics Vs. Can Fite Biofarma Industry Stock Comparison

Sell
50

CMMB
Chemomab Therapeutics

Last Price:
0.87
Seasonality Move:
-7.77%
Buy
54

CANF
Can Fite Biofarma

Last Price:
2.40
Seasonality Move:
-8.35%
Sell
50
Chemomab Therapeutics (CMMB) is a Sell

Is Chemomab Therapeutics a Buy, Sell or Hold?

  • The current Chemomab Therapeutics [CMMB] share price is $0.84. The Score for CMMB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CMMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Can Fite Biofarma (CANF) is a Buy

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $2.38. The Score for CANF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • CANF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CMMB Stock Price Chart

What is Chemomab Therapeutics's stock price today?

  • The Chemomab Therapeutics share price today is $0.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMMB is experiencing selling pressure, which indicates risk of future bearish movement.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $2.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CANF is experiencing buying pressure, which is a positive indicator for future bullish movement.

CMMB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 56.3 Buy
Chaikin Money Flow: -24642 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.65 - 0.83) Buy
Bollinger Bands (100): (0.57 - 0.79) Buy

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 65.31 Buy
Chaikin Money Flow: 30742 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.96 - 2.16) Buy
Bollinger Bands (100): (1.99 - 2.21) Buy

CMMB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.83 Buy
20-day SMA: 0.76 Buy
50-day SMA: 0.76 Buy
200-day SMA: 0.75 Buy
8-day EMA: 0.84 Buy
20-day EMA: 0.79 Buy
50-day EMA: 0.75 Buy
200-day EMA: 0.91 Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.15 Buy
20-day SMA: 2.07 Buy
50-day SMA: 2.15 Buy
200-day SMA: 2.24 Buy
8-day EMA: 2.18 Buy
20-day EMA: 2.12 Buy
50-day EMA: 2.12 Buy
200-day EMA: 2.46 Sell

Chemomab Therapeutics Earnings Growth & CMMB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.02 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

Chemomab Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):